News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Up to 40% of cancers from the human papillomavirus occur in men – European Cancer Organisation
hollingscancercenter.musc.edu
Mar 2, 2025, 09:14

Up to 40% of cancers from the human papillomavirus occur in men – European Cancer Organisation

European Cancer Organisation posted on LinkedIn:

“Think HPV affects only women? Think again.

Up to 40% of cancers from the human papillomavirus occur in men. But most have no idea there’s an effective way to prevent all of them.

That’s why gender-neutral vaccination and screening are so vitally important throughout Europe.

On 4 March, HPV Awareness Day, let’s learn the facts and spread the word. We all have a role to play!”

Read Further.

Up to 40% of cancers from the human papillomavirus occur in men - European Cancer Organisation

cancer European Cancer Organisation HPV Awareness Day OncoDaily Oncology
Special Coverage
Blog
Apr 1, 2025, 17:28
Ester Demirtshyan: Consider donating $10 to City of Smile to help children fighting cancer in Armenia
Blog
Apr 1, 2025, 17:18
Exploring AI’s Role in Cancer Care at ESTRO 2025
Blog
Apr 1, 2025, 17:01
The Power Over Cancer Gathering at Springhill Church - UF Health Cancer Center
Blog
Apr 1, 2025, 16:40
Estelamari Rodriguez: Speaking at the Latino Medical Student Association regional conference
Blog
Apr 1, 2025, 16:32
Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers
Blog
Apr 1, 2025, 16:21
Azra Raza featured in SPCC's fifth episode of the "Behind Every Drug There’s a Story" series
Blog
Apr 1, 2025, 16:18
The EBMT 2025 Election Results
Career
Apr 1, 2025, 16:02
Jay Bhattacharya begins his tenure as the 18th NIH Director - National Institutes of Health
Positive
Apr 1, 2025, 15:45
Mark Lanasa: Positive CHMP opinion for BeOne Medicines' first-line immunotherapy in ES-SCLC
Blog
Apr 1, 2025, 15:09
Hagop Kantarjian: Success, optimism, and challenges on the therapeutic horizon of acute myeloid leukemia
Blog
Apr 1, 2025, 15:04
Call for Papers: AI in Immune-Related Adverse Events (irAEs) - AI in Precision Oncology
Career
Apr 1, 2025, 14:57
Sharon Burk completes PhD with groundbreaking research - Sbarro Health Research Organization